North Shore Hematology / Oncology Associates, PC.

SPRING
2014
NSHOA
news
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES, P.C.
CONQUERING CANCER...CLOSE TO HOME™
631-751-3000 NSHOA.COM
North Shore Hematology / Oncology Associates, PC.
Conquering Cancer… Close to Home®
North Shore Hematology Oncology Associates, PC was honored to
welcome U.S. Rep. Steve Israel to our Smithtown office to meet with
Dr. Vacirca and view our facility. Rep. Israel and Dr. Vacirca discussed
the many pressing issues and headwinds facing community
oncology. Topics of discussion included a permanent fix to the SGR,
340b, continued support of HR 1416, HR 800, Oncology Medical
Home, payment reform, Stark exemption and NGS reimbursement.
We understand the demands Rep. Israel has on his schedule and
both NSHOA and our patients appreciate the time spent and we look
forward to working in tandem with the Congressman on all oncology
related matters going forward to help preserve community oncology.
U.S. Rep. Steve Israel & Dr. Vacirca
North Shore Hematology Oncology Associates, PC was honored to welcome U.S. Rep. Steve Israel to
Smithtown office to meet with Dr. Vacirca and view our facility. Rep. Israel and Dr. Vacirca discussed
many pressing issues and headwinds facing community oncology. Topics of discussion include
permenant fix to the SGR, 340b, continued support of HR 1416, HR 800, Oncology Medical Ho
payment reform, Stark exemption and NGS reimbursement. We understand the demands Rep. Israe
North Shore
Hematology
Oncology
PC.thehas
uplook forwar
on his schedule
and both NSHOA
and ourAssociates,
patients appreciate
time teamed
spent and we
workingPatients
in tandemAdvocacy
with the Congressman
all oncology
related matters
forward to
with COA’s
Network on
(CPAN)
to launch
a NY going
based
preserve community oncology.
chapter for community cancer patient advocacy. With tremendous
support from the practice, a kickoff meeting was held on November 19,
2013 at one of the NSHOA offices. In a room filled with advocates, Dr.
Jeffrey Vacirca, Michael Murray and Nicole Cardaci-Gregory from North
Shore Hematology Oncology Associates along with Rose Gerber from
CPAN spoke to the importance of care in our community oncology
clinics. Advocates were educated on the various roles that they
can undertake and the positive impact they can have on their care.
(CPAN)
ocacy Network
’s Patients Adv
e,
COA
ctic
h
pra
wit
the
up
On an open floor, the advocates expressed their personal stories,
t from
has teamed
mendous suppor
y Associates, PC.
ocacy. With tre
with advocates,
atology Oncolog
In a room filled
cancer patient adv
.
nity
ices
y
North Shore Hem
mu
off
olog
A
com
HO
Onc
for
atology
and
desire
to help make a change. The meeting concluded with excitement and interest
ed chapter
one of the NS
at challenges
Shore Hem
to launch a NY bas
ember 19, 2013
ory from North
oncology clinics.
was held on Nov
ole Cardaci-Greg
our community
kickoff meeting
Murray and Nic
ance of care in
haelNY
y can have onsteps will include plans to have advocates attend the COA conference in
import
Mic
the
,
the
act
irca
in aDr.making
the
chapter
a
success.
The
next
to
imp
ke
e
Vac
y
itiv
spo
Jeffre
e
ber from CPAN
ake and the pos
desire to help mak
g with Rose Ger
t they can undert
, challenges and
Associates alon
various roles tha
s. The next
ir personal stories NY chapte
thecoordination
r a succesCPAN
e educated on the
Disney
World.
NSHOA
in
with
expressed
tes
the
n look forward to working with these advocates to enhance patient care.
Advocates wer
oca
ing
atio
adv
mak
rdin
the
in
coo
in
rest
open floor,
World. NSHOA
itement and inte
their care. On an
cluded with exc
ference in Disney
COA con
meeting con
If you
are
interested
in
becoming
a
patient
advocate for the NY chapter please email [email protected]
attend the
e.
car
tes
t
a change. The
oca
ien
m
adv
pat
e
s to hav
to enhance
[email protected]
plan
ocates
se email advoca
steps will include
g with these adv
NY chapter plea
forward to workin
advocate for the
with CPAN look
oming a patient
bec
in
ted
res
If you are inte
Open 7 days a week, 365 days a year
Setauket- Patchogue- Smithtown- Brightwaters- Port Jefferson
Chemotherapy Infusion Centers, Radiation Therapy, Clinical Trials, Diagnostic Imaging, Pathology, Chemistry & Hematology Labs, CTC Testing
Proud Participants
North Shore Hematology Oncology Associates’
participation in the ABRAXIS CA046 clinical
research trial has led to the approval of a new
drug combination that is offering hope to people
with a deadly form of pancreatic cancer. The trial
was a Phase III Randomized Study of Weekly
ABI-007 plus Gemcitabine versus Gemcitabine
Alone in 1st Line Treatment of Patients with
Metastatic
Pancreatic
Adenocarcinoma.
Over the past decade, pancreatic cancer death rates
have been slowly increasing among Americans, in
contrast to the downward trend among other cancer
types, including lung, colon, breast, and prostate
cancers. Most pancreatic cancer patients are not
diagnosed until their cancer is already advanced,
and most do not survive longer than 1 year.
Researchers are taking up the challenge to find
new methods of prevention, early diagnosis, and
treatment for pancreatic cancer. Studies have
found that adding Abraxane (nab-paclitaxel) to a
standard chemotherapy treatment helped people
with advanced pancreatic cancer live longer.
Gemzar (gemcitabine) is the chemo drug used
most often to treat pancreatic cancer. It’s now
been shown that adding Abraxane significantly
improved survival. Researchers studied Abraxane
in 861 pancreatic cancer patients in 11 countries
by giving half of them Abraxane and Gemzar,
and half of them Gemzar alone. The rate of
survival was significantly higher in the AbrazaneGemzar group. Members of that group lived
an average 1.8 months longer than those who
received Gemzar alone. It also took an average
of 1.8 months longer for their cancer to get worse.
In addition, 35% of patients who received
Abraxane lived for more than 1 year, compared
to 22% who received Gemzar alone, and 9% who
received Abraxane lived for more than 2 years,
compared to 4% who received Gemzar alone.
Kudos to our Practice for participating in such trials!
Conquering Cancer...
Now Even Closer To Home
NSHOA is coming to the East End
Summer 2014
Our doors are open to you, 7 days a week, 365 days a year
Chemotherapy Infusion Centers • Radiation Therapy • Clinical Trials
Diagnostic Imaging • Pathology • Chemistry & Hematology Labs • CTC Testing
Setauket • Patchogue • Smithtown • Brightwaters • Port Jefferson
Long Island’s Premier Comprehensive Cancer Treatment Center
CONQUERING CANCER...
CLOSE TO HOME ®
631.751.3000
NSHOA.COM
Open 7 days a week, 365 days a year
Setauket- Patchogue- Smithtown- Brightwaters- Port Jefferson
Chemotherapy Infusion Centers, Radiation Therapy, Clinical Trials, Diagnostic Imaging, Pathology, Chemistry & Hematology Labs, CTC Testing